Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.
Open Access
- 1 May 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 91 (5) , 2275-2280
- https://doi.org/10.1172/jci116455
Abstract
Approximately 2% of Caucasians and African-Americans are homozygous for a nonsense mutation in exon 2 of the AMPD1 (AMP deaminase) gene. These individuals have a high grade deficiency of AMPD activity in their skeletal muscle. More than 100 patients with AMPD1 deficiency have been reported to have symptoms of a metabolic myopathy, but it is apparent many individuals with this inherited defect are asymptomatic given the prevalence of this mutant. Results of the present study provide a potential molecular explanation for "correction" of this genetic defect. Alternative splicing eliminates exon 2 in 0.6-2% of AMPD1 mRNA transcripts in adult skeletal muscle. Expression studies document that AMPD1 mRNA, which has exon 2 deleted, encodes a functional AMPD peptide. A much higher percentage of alternatively spliced transcripts are found during differentiation of human myocytes in vitro. Transfection studies with human minigene constructs demonstrate that alternative splicing of the primary transcript of human AMPD1 is controlled by tissue-specific and stage-specific signals. Alternative splicing of exon 2 in individuals who have inherited this defect provides a mechanism for phenotypic rescue and variations in splicing patterns may contribute to the variability in clinical symptoms.Keywords
This publication has 23 references indexed in Scilit:
- Molecular analysis of the myoadenylate deaminase deficienciesNeurology, 1992
- Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in ten subjects determined by direct sequencing of amplified transcripts.Journal of Clinical Investigation, 1989
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proceedings of the National Academy of Sciences, 1989
- A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man.Journal of Clinical Investigation, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.Journal of Clinical Investigation, 1983
- Familial myoadenylate deaminase deficiency and exertional myalgiaNeurology, 1982
- Myoadenylate deaminase deficiencyMuscle & Nerve, 1979
- Myoadenylate Deaminase Deficiency: A New Disease of MuscleScience, 1978
- Development of 3T3‐like lines from Balb/c mouse embryo cultures: Transformation susceptibility to SV40Journal of Cellular Physiology, 1968